share_log

Jefferies Initiates Coverage On BioLife Solns With Buy Rating, Announces Price Target of $22

Moomoo 24/7 ·  Apr 4 07:18

Jefferies analyst Matthew Stanton initiates coverage on BioLife Solns (NASDAQ:BLFS) with a Buy rating and announces Price Target of $22.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment